Enlaza
PrivateLast Round
Early Funding
Sep 10, 2025
Total Funding Raised
$176M
Momentum Score
25 /100
Company Overview
Enlaza Therapeutics is a biopharmaceutical company focused on developing covalent protein therapeutics to provide safer treatment options.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enlaza Comps
Public and private peers based on sector, stage, and business model.
Enlaza Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 10, 2025 | ||||
| Series A | Apr 30, 2024 | ||||
| Seed | Dec 15, 2022 |
Enlaza Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pappas Capital | Series A |
| Regeneron Ventures | Series A |
| J.P. Morgan Private Capital | Series A |
| Frazier Life Sciences | Seed, Series A |
| Avalon Ventures | Series A, Seed |
| Amgen Ventures | Series A |
| Samantha | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2025
$15M raised in early funding.
- Sep 2, 2025
Partnered with Vertex Pharmaceuticals on multi-target drug discovery.
Enlaza Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enlaza's valuation, stock price, and market status.
